Impact of patient outcomes and cost aspects on reimbursement recommendations in Poland in 2012–2014
Krzysztof Piotr Malinowski,
Paweł Kawalec and
Health Policy, 2016, vol. 120, issue 11, 1249-1255
The aim of this study was to assess the influence of different factors on the final reimbursement recommendations for drugs in Poland and to identify the correlation between these factors and the probability of a positive reimbursement recommendation for an applicant drug issued by the President of the Agency for Health Technology Assessment and Tariff System (AOTMiT).
Keywords: Agency for Health Technology Assessment and Tariff System; AOTMiT; Reimbursement recommendations; Health technology assessment; Poland (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations Track citations by RSS feed
Downloads: (external link)
Full text for ScienceDirect subscribers only
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:120:y:2016:i:11:p:1249-1255
Access Statistics for this article
Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput
More articles in Health Policy from Elsevier
Series data maintained by Dana Niculescu ().